GRRMF Stock - Gerresheimer AG
Unlock GoAI Insights for GRRMF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.04B | $1.99B | $1.82B | $1.50B | $1.42B |
| Gross Profit | $607.76M | $597.31M | $546.81M | $442.23M | $437.61M |
| Gross Margin | 29.9% | 30.0% | 30.1% | 29.5% | 30.8% |
| Operating Income | $197.47M | $213.39M | $169.31M | $147.44M | $156.46M |
| Net Income | $109.72M | $116.13M | $96.12M | $83.79M | $88.56M |
| Net Margin | 5.4% | 5.8% | 5.3% | 5.6% | 6.2% |
| EPS | $3.18 | $3.48 | $3.06 | $2.67 | $2.82 |
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson's disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.
Visit WebsiteEarnings History & Surprises
GRRMFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 9, 2026 | — | — | — | — |
Q4 2025 | Oct 14, 2025 | $0.95 | $0.81 | -15.5% | ✗ MISS |
Q3 2025 | Jul 10, 2025 | $0.92 | $0.56 | -38.9% | ✗ MISS |
Q2 2025 | Apr 9, 2025 | $0.39 | $-0.54 | -240.5% | ✗ MISS |
Q4 2024 | Nov 30, 2024 | — | $1.14 | — | — |
Q4 2024 | Oct 10, 2024 | $1.18 | $1.15 | -2.5% | ✗ MISS |
Q3 2024 | Jul 11, 2024 | $1.24 | $1.24 | 0.0% | = MET |
Q2 2024 | Apr 11, 2024 | $0.64 | $0.65 | +1.6% | ✓ BEAT |
Q4 2023 | Nov 30, 2023 | — | $1.31 | — | — |
Q4 2023 | Oct 5, 2023 | $1.11 | $1.07 | -3.6% | ✗ MISS |
Q3 2023 | Jul 6, 2023 | $1.28 | $1.30 | +1.6% | ✓ BEAT |
Q1 2023 | Feb 23, 2023 | $1.47 | $1.49 | +1.4% | ✓ BEAT |
Q4 2022 | Nov 30, 2022 | — | $1.10 | — | — |
Q4 2022 | Oct 12, 2022 | $1.25 | $1.15 | -8.0% | ✗ MISS |
Q3 2022 | Jul 13, 2022 | $1.20 | $1.34 | +11.7% | ✓ BEAT |
Q2 2022 | Apr 7, 2022 | $0.63 | $0.63 | 0.0% | = MET |
Q4 2021 | Nov 30, 2021 | — | $0.98 | — | — |
Q4 2021 | Oct 12, 2021 | $1.00 | $0.97 | -3.0% | ✗ MISS |
Q3 2021 | Jul 13, 2021 | $1.16 | $1.28 | +10.3% | ✓ BEAT |
Q2 2021 | Apr 8, 2021 | $0.44 | $0.57 | +29.5% | ✓ BEAT |
Latest News
Frequently Asked Questions about GRRMF
What is GRRMF's current stock price?
What is the analyst price target for GRRMF?
What sector is Gerresheimer AG in?
What is GRRMF's market cap?
Does GRRMF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GRRMF for comparison